Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 23, 2017
Pharmacy Choice - Pharmaceutical News - Active Pharmaceutical Ingredients (API) Market to Reach USD 224.63 Billion by 2022 - October 23, 2017

Pharmacy News Article

 5/17/17 - Active Pharmaceutical Ingredients (API) Market to Reach USD 224.63 Billion by 2022

Global Active Pharmaceutical Ingredients (API) Market worth USD 154.88 billion in 2016 and expected to reach USD 224.63 billion by 2022, at a CAGR of 6.4% from 2016 to 2022.Chicago, IL (SBWIRE) 05/17/2017 According to the new market research report, "Active Pharmaceutical Ingredients (API) Market, by Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biological), Drug Type (Generics, Branded), Classification (HPAPI, Others), Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, CNS, Oncology, Musculoskeletal Diseases, NSAIDs, Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global active pharmaceutical ingredient (API) market is expected to grow at a steady CAGR of 6.4% and reach USD 224.63 billion by the year 2022.

Request Sample:

The global active pharmaceutical ingredients (API) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Early buyers will receive 10% free customization on this report.

Enquiry Before Buying:

Key findings of the report:

1. According to the report, the rapid advancements in biologics are one of the major driving factors for the global active pharmaceutical ingredients (API) market.

2. Apart from that, the rising local manufacturing and the growth in the number of aging population are also expected to drive the global active pharmaceutical ingredient (API) market during the forecast period.

3. The increasing awareness towards generic drugs and the growing government initiatives are also expected to boost the growth of the active pharmaceutical ingredients (API) market during the forecast period.

Detailed segmentation analysis of the active pharmaceutical ingredients (API) market

The report segments the global active pharmaceutical ingredient (API) market by manufacturers, synthesis, drug types, classifications, therapeutic areas, and geographic regions. The manufacturer segments are further divided into merchant and captive. The synthesis segment includes biological and synthetic. The drug types include generic and branded. The classifications include HPAPI and others. The therapeutic areas include metabolic disorders, cardiovascular diseases, NSAIDs, CNS, musculoskeletal diseases, oncology, and others. Based on the geographic regions, the global active pharmaceutical ingredient (API) market is further divided into North America, Asia-Pacific, Europe, and Rest of the World.

Browse Report Summary:

The active pharmaceutical ingredients (API) market report provides analysis of the key players, including:

1. Teva Pharmaceutical Industries, Ltd
2. Sun Pharmaceutical Industries Ltd
3. Dr.Reddy's Laboratories
4. Aurobindo Pharma Ltd
5. Mylan N.V
6. Novartis AG
7. Cambrex Corporation
8. Boehringer Ingelheim GmbH
9. Pfizer, Inc
10. Lonza Group

About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.

Scalar Market Research is a portfolio company of ALCOR GROUP, a Chicago, U.S.-based Mergers & Acquisitions giant with immense experience and connection with more than 1500 global funds which include leading Angel, VC, PE, Hedge, LBO, and Buyout Funds. ALCOR also deals in other services including Fund & Asset Management, Private Equity, and Corporate Finance. Our strong connection with the ALCOR GROUP of companies gives us an extra edge in delivering unique business intelligence.

Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, works relentlessly to help our clients realize their most important business goals.

Find out more about our services at: www.scalarmarketresearch.comFor more information on this press release visit:

Media Relations Contact

George Molakal
Scalar Market Research
Telephone: 800-213-5170
Email: Click to Email George Molakal

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Oct 23: Vitamin D Primer for Pharmacy Professionals
Last Chance
Oct 24: Metabolic Syndrome: The Heart of Any Wellness Practice
Oct 25: Dispensing Controlled Substances in Today’s Pharmacy
Oct 26: Management of Schizophrenia & Acute Agitation
Oct 27: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement